Depressive disorder
|
0.460 |
Biomarker
|
disease |
BEFREE |
This study investigated whether there exist distinctive patterns of presynaptic monoamine transporter densities in the basal ganglia depending on the degree of depression in patients with PD.
|
31377233 |
2019 |
Depressive disorder
|
0.460 |
Biomarker
|
disease |
BEFREE |
In summary, Δ<sup>3</sup>,2-hydroxybakuchiol exerts antidepressant effects on various types of depression models through a possible mechanism of monoamine transporter inhibition.
|
30026780 |
2018 |
Depressive disorder
|
0.460 |
Biomarker
|
disease |
PSYGENET |
However, alterations in anxiety- and depression-regulating genes were present in the hypothalamus of BACHD mice including reduced mRNA expression of neuropeptide Y, tachykinin receptor 3 and vesicular monoamine transporter type 2 as well as increased expression of cocaine and amphetamine regulated transcript.
|
23697793 |
2013 |
Depressive disorder
|
0.460 |
AlteredExpression
|
disease |
BEFREE |
However, alterations in anxiety- and depression-regulating genes were present in the hypothalamus of BACHD mice including reduced mRNA expression of neuropeptide Y, tachykinin receptor 3 and vesicular monoamine transporter type 2 as well as increased expression of cocaine and amphetamine regulated transcript.
|
23697793 |
2013 |
Depressive disorder
|
0.460 |
Biomarker
|
disease |
PSYGENET |
Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
|
19468717 |
2009 |
Depressive disorder
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
|
19468717 |
2009 |
Depressive disorder
|
0.460 |
Biomarker
|
disease |
BEFREE |
This study tested for an association between SLC18A2 and ADRB1 and treatment outcome in 873 major depressive disorder patients treated with the antidepressant citalopram in the Sequenced Treatment Alternatives to Relieve Depression study.
|
18797399 |
2008 |
Depressive disorder
|
0.460 |
Biomarker
|
disease |
PSYGENET |
Bakuchiol analogs, especially Delta3,2-hydroxybakuchiol, are monoamine transporter inhibitors involved in regulating dopaminergic and noradrenergic neurotransmission and may have represented potential pharmacotherapies for disorders such as Parkinson's disease, depression, and cocaine addiction.
|
18329002 |
2008 |
Depressive disorder
|
0.460 |
Biomarker
|
disease |
PSYGENET |
This study tested for an association between SLC18A2 and ADRB1 and treatment outcome in 873 major depressive disorder patients treated with the antidepressant citalopram in the Sequenced Treatment Alternatives to Relieve Depression study.
|
18797399 |
2008 |
Depressive disorder
|
0.460 |
Biomarker
|
disease |
PSYGENET |
Candidate gene polymorphisms in the serotonergic pathway: influence on depression symptomatology in an elderly population.
|
16806099 |
2007 |
Depressive disorder
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
|
17018806 |
2006 |
Depressive disorder
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|